Pharmaceutical News and Articles

Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION)

Multimodal Computational Framework Can Predict Prognosis of Myelodysplastic Syndromes

A multimodal computational framework for patient stratification and prognosis prediction enables automatic identification of patient clusters, outperforming cla

Advisory Committee on Immunization Practices February Meeting Postponed

The latest meeting of the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) has been postponed indefinitely to

LA Wildfires Spewed Lead Into Atmosphere

The Los Angeles wildfires spewed toxic lead into the southern California atmosphere during their rampage, a new U.S. Centers for Disease Control and Prevention

Young Women's Locale Plays Role In Breast Cancer Risk

Where a young American woman lives could play a role in her risk for breast cancer, a new study suggests. In fact, the breast cancer risk associated with a youn

Rapid Gene Test Aids Brain Cancer Surgery

A rapid experimental genetic test can help guide the hands of surgeons as they delicately remove tumors from patients with brain cancer, new research suggests.

MS Patients May Benefit From Eating More Fish

A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says. The nutrients found in fish can quell inflammation and

A Suicide Death Occurs Every 43 Seconds Worldwide

A person dies by suicide once every 43 seconds, and it s more than likely a man, according to a new global assessment of suicide risk. Men die from suicide at t

FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy

Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia

Newton, MA, February 24, 2025 Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient out comes in oncolog